Last reviewed: July 3, 2026
Last updated: July 3, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by binding to GLP-1 receptors throughout your body, triggering a cascade of metabolic changes that reduce hunger and increase satiety. Clinical trials show that people using semaglutide lose 5–22% of body weight depending on dose and individual response. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, starting at $149 per month with personalized dosing support.
The GLP-1 Receptor: Your Body's Natural Weight-Control Switch
GLP-1 is a hormone your intestines naturally produce when you eat carbohydrates or protein. It signals your brain's appetite centers that you are full, slows how fast your stomach empties food into the small intestine, and stabilizes blood sugar. Semaglutide mimics this natural hormone with much higher potency and a longer half-life—meaning one injection lasts about a week instead of minutes.
When semaglutide binds to GLP-1 receptors in the hypothalamus and brainstem, it activates neural pathways that suppress hunger hormones like ghrelin while amplifying satiety signals. This dual action makes you feel fuller sooner, eat less overall, and experience reduced cravings between meals. Studies show that GLP-1 receptor activation alone accounts for roughly 50% of the weight loss achieved with semaglutide.
How Semaglutide Slows Digestion and Controls Blood Sugar
Semaglutide slows gastric emptying—the rate at which food leaves your stomach. This delayed digestion prolongs fullness after eating and prevents rapid blood sugar spikes that trigger hunger rebounds. By extending nutrient absorption over a longer period, your body maintains steadier energy levels and reduced appetite throughout the day.
The medication also enhances insulin secretion in response to blood glucose, helping to regulate blood sugar levels more effectively. This metabolic stabilization creates an environment where your body naturally burns fat stores more readily. People with insulin resistance or prediabetes often experience additional metabolic benefits beyond weight loss alone.
Semaglutide's Effect on Appetite-Regulating Hormones
Your body produces two opposing hormones that control hunger: ghrelin (the 'hunger hormone') and leptin (the 'fullness hormone'). Semaglutide reduces ghrelin production while enhancing leptin sensitivity, creating a powerful hormonal environment that naturally suppresses appetite. Clinical data shows this hormonal rebalancing persists as long as you continue the medication.
Beyond appetite suppression, semaglutide affects reward pathways in your brain related to food craving. Neuroimaging studies reveal that the medication reduces activity in brain regions associated with food desire, making it easier to stick to a calorie deficit without constant willpower. This neurobiological shift explains why many patients report that eating less feels effortless rather than restrictive.
Individual Response Varies: Why Genetic Testing Matters
Not everyone loses the same amount of weight on the same dose of semaglutide. Genetic factors influence how strongly your GLP-1 receptors respond to the medication, how efficiently you metabolize it, and which metabolic pathways dominate your weight regulation. PlexusDx offers the Precision Peptide Genetic Test to map 14 metabolic pathways and 49 peptides, revealing genetic variants like GLP1R rs6923761 and GIPR rs1800437 that predict your treatment response.
Understanding your genetic predisposition helps PlexusDx providers personalize your starting dose, titration schedule, and medication selection. Some patients achieve excellent results with lower doses, while others require higher doses for the same effect. This precision approach maximizes efficacy while minimizing unnecessary side effects and cost.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does semaglutide work immediately or take time to start suppressing appetite?
Most patients notice appetite reduction within 3–5 days of the first injection as GLP-1 receptor activation begins. However, meaningful weight loss typically becomes evident after 2–4 weeks as your body adapts and you naturally consume fewer calories. PlexusDx providers monitor your response at each dose escalation to ensure you reach your therapeutic window safely.
What percentage of weight loss can I expect with semaglutide?
Clinical trials show average weight loss of 5–22% of body weight depending on dose, duration, and individual factors. At the highest maintenance doses, some patients achieve 18–22% weight loss when combined with lifestyle modifications. Individual results vary based on genetics, starting weight, adherence, and metabolic factors that the Precision Peptide Genetic Test can help predict.
How much does semaglutide cost at PlexusDx, and does the price change with dose increases?
PlexusDx compounded semaglutide injections start at $149 per month, and your dose may need to go up—but your price won't. This flat-rate pricing across all dose levels removes barriers to finding your optimal therapeutic dose. No insurance is required, HSA/FSA funds are accepted, and all medications come from licensed 503A compounding pharmacies.
Are there side effects, and can they limit how much semaglutide I can tolerate?
Common side effects include nausea, constipation, and vomiting, particularly during dose increases. These typically resolve within 1–2 weeks as your body adjusts. Serious side effects are rare but may include gallbladder issues or pancreatitis. PlexusDx providers start with low doses and increase gradually to minimize nausea while allowing your body to adapt, helping most patients reach effective doses.
How does the Precision Peptide Genetic Test help with semaglutide treatment?
The test identifies genetic variants in GLP1R, GIPR, FTO, MC4R, and other key genes that influence how your body responds to semaglutide. Results guide optimal dosing and help predict whether you'll respond best to semaglutide alone or combination therapies like GLP-Squared. At $99 after your first month of treatment, it personalizes your care plan and reduces trial-and-error dosing.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimal Dosing: Can You Take Ozempic More Than Once a Week?
Mastering Your Zepbound Routine: Precision Dosing for Effective Weight Management